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Abstract
We report a 47 year-old male patient with coexistence of left ventricular noncompaction and
Brugada syndrome. He presented malignant ventricular arrhythmias followed by cardioverter-
-defibrillator implantation, atrial fibrillation and flutter and progressive heart failure. This
case could be an example of the coexistence of two rare diseases of various genetic patterns that
only partially showed overlapping symptomatology and complications, particularly ventricular
arrhythmias. (Cardiol J 2011; 18, 3: 310–313)
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Introduction
Left ventricular noncompaction (LVNC) is a rare
congenital, genetic, primary cardiomyopathy, re-
sulting from an arrest of compaction of the loose
mesh of cardiac muscle fibers during embryogene-
sis [1]. Morphologically, it is characterized by the
presence of two myocardial layers: a thin epicardial
layer and a thick noncompacted endocardial layer
with deep intertrabecular recesses, which commu-
nicate with the ventricular cavity [2–4]. The pre-
valence of the disease is estimated to be 0.05% of
the adult population [1].
Left ventricular noncompaction may be an iso-
lated malformation or may be associated with other
congenital heart diseases, such  as left or right ven-
tricular outflow tract obstruction or pulmonary atre-
sia without interventricular septal defect [2, 3]. This
association has been shown to result from mutations
in the alpha-dystrobrevin gene and transcription fac-
tor NKX2.5 [1]. In patients with an isolated form of
LVNC, mutations in the G4.5 gene have been report-
ed [1, 5]. Left ventricular noncompaction may coe-
xist with neuromuscular disorders (e.g. Becker mus-
cular dystrophy) and with facial dysmorphism [6, 7].
Since the first description of LVNC published
in 1990 by Chin et al. [4] interest in this specific
cardiomyopathy has increased mainly due to its
natural history, which includes left ventricular dys-
function leading to heart failure, arrhythmias, sud-
den cardiac death and thromboembolism.
Brugada syndrome is an autosomal dominant
inherited disease characterized by an ST-segment
elevation in the right precordial leads and a high
incidence of sudden cardiac death due to malignant
ventricular arrhythmias [8]. The syndrome is linked
to mutations in gene SCN5A, which encodes for the
alpha-subunit of the cardiac sodium channel [9].
However, SCN5A mutations account for only 20–
–30% of Brugada syndrome cases. The prevalence
of the syndrome is estimated to be 5–58 per 10,000
inhabitants, but the true prevalence is difficult to
assess because of the dynamic and often concealed
character of the ECG Brugada pattern [8].
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We present the case of a 47 year-old man with
electrocardiographic features and clinical symptoms
of Brugada syndrome and echocardiographic find-
ings characteristic of LVNC.
Case report
A 47 year-old man with two episodes of cardiac
arrest due to ventricular fibrillation (VF) and fast
ventricular tachycardia (VT) (Fig. 1) was referred
to our hospital for implantation of a cardioverter-
-defibrillator (ICD). His medical history included
several episodes of syncope, paroxysmal atrial fi-
brillation (AF) and flutter (AFL), psoriasis, arterial
hypertension and type 2 diabetes mellitus. His two
brothers died suddenly at the ages of 28 and 47.
Twelve-lead electrocardiogram (ECG) showed
normal sinus rhythm and typical Brugada pattern
type 1 (coved-type) (Fig. 2). Transthoracic echocar-
diography revealed a slightly enlarged hypokinetic
left ventricle with left ventricular end-diastolic dia-
meter of 61 mm, and ejection fraction of 45%. More-
over, a markedly thickened endocardium in the api-
cal region of anterior and lateral walls with enhanced
trabeculation and deep intertrabecular recesses was
found (Fig. 3). The ratio of noncompacted layer to
Figure 1. Electrocardiogram showing fast ventricular
tachycardia.
Figure 2. Twelve-lead electrocardiogram showing nor-
mal sinus rhythm and typical Brugada pattern type 1
(coved-type).
Figure 3. Transthoracic two-dimensional echocardio-
gram in short axis showing markedly thickened endo-
cardium with noncompacted (NCM) and compacted
(LVAW) layers; LV — left ventricle.
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compacted myocardium was 2.0, which accords with
the Oechslin diagnostic for LVNC [10].
Coronary angiography revealed normal coro-
nary arteries, and 24-hour Holter monitoring
showed sinus rhythm with a lowest heart rate of
40 bpm during the day and 28 bpm at night.
A dual-chamber cardioverter-defibrillator (Ta-
chos DR, Biotronik, Germany) was implanted. VF
detection zone (< 260 ms), and two VT zones
(< 300 ms, < 350 ms) were programmed. Pro-
grammed ICD therapy included shocks on VF, and
antitachycardia pacing (ATP) followed by shocks on
VT. The patient was discharged home on pharma-
cological treatment: quinapril, metoprolol, insulin
and metphormin. On one month follow-up, a high
ventricular pacing threshold was diagnosed. Tem-
porary steroid therapy was implemented.
Five months later, he developed arrhythmic
storm due to multiple episodes of monomorphic VT.
Amiodarone was started. Because of the recurrence
of a high ventricular pacing threshold (> 5 V, 0.4 ms),
an additional pace/sense lead was implanted.
Over the next six months he experienced se-
veral inappropriate ICD therapies (shocks and ATP)
caused by AFL with fast ventricular response. Cavot-
ricuspid isthmus ablation was performed. Three
months later, however, three consecutive inappro-
priate ICD shocks due to AF and atypical AFL were
documented. The patient refused left atrial ablation,
thus modification of atrioventricular (AV) node with
prolongation of AV conduction to 300 ms was per-
formed. For the 18 months following ICD implanta-
tion, he presented permanent AF. Acenocoumarol was
added to his pharmacological regimen.
During the next follow-up, episodes of mono-
morphic VT (in fast VT zone) successfully terminat-
ed by ATP or cardioversion were observed. The fol-
low-up echocardiographic studies revealed a constant
progression of the left ventricular dysfunction with
a decrease of ejection fraction to 35% and increase
of left ventricular end-diastolic diameter to 71 mm
on last visit (three years after ICD implantation).
Moreover, in the apical region of anterior and lateral
walls, akinesis and slight thinning of the noncompact-
ed layer were found. The patient was screened for
cardiac resynchronization therapy, but no signs of in-
ter- and/or intraventricular dyssynchrony were found.
Discussion
Left ventricular noncompaction may coexist
with various ECG abnormalities such as ST seg-
ment depression, negative T-wave, bundle branch
blocks, pathologic Q-wave, sinus bradycardia, Wolff-
-Parkinson-White syndrome and atrial arrhythmias
[6, 10, 11]. Malignant ventricular arrhythmias are
common in LVNC (40%). About 50% of patients die
suddenly [6, 10].
To the best of our knowledge, this is the first
report of the coexistence of LVNC and Brugada
syndrome. Both pathologies present in their clini-
cal symptomatology as supraventricular and ven-
tricular arrhythmias [6, 8, 10]. Most patients at the
time of LVNC diagnosis have left ventricular sys-
tolic and/or diastolic dysfunction; and during follow-
-up, half of them develop severe heart failure [10].
The most pronounced contraction abnormali-
ties were found in our patient in the apical region
of anterior and lateral walls, thus in the noncom-
pacted parts of the left ventricle. The pathophysio-
logical mechanisms of heart failure and ventricular
arrhythmias in patients with LVNC are unclear.
Coronary microcirculation dysfunction and ischemia
may play a role in the progression of the disease
[12]. In our case, paroxysmal AFL and AF were
additional factors predisposing to faster heart fail-
ure progression. Documented fast VT (250 bpm)
(Fig. 1) was differentiated with AFL with 1:1 AV
conduction and intraventricular aberration. Intra-
cardiac recordings from double-chamber ICD were
helpful, and showed a clear difference between AFL,
which presented a regular AV relationship, and VT
with ventriculoatrial block. Episodes of fast regu-
lar tachycardia with wide QRS complexes of the
same morphology after cavotricuspid ablation and
AV node modification supported the statement that
this tachycardia is not an atrial flutter.
Genetic testing for Brugada syndrome corre-
sponded to a positive result of previously unknown
mutation (type 2). It meant that the patient had
a genetic defect potentially responsible for the dise-
ase. To assess whether this mutation causes Bru-
gada syndrome, it would be helpful to screen other
family members. Unfortunately, this, and the genetic
testing for LVNC, could not be performed.
The described case could be an example of co-
existence of two rare diseases of various genetic
patterns and pathogenesis that only partially
showed overlapping symptomatology and compli-
cations. In a given case it is difficult to say which
pathology is responsible for the malignant ventri-
cular arrhythmias. The secondary prevention of
sudden cardiac death is of paramount importance.
Despite major progress in diagnosing and iden-
tifying the cellular mechanisms responsible for the
development of Brugada syndrome in particular, no
major progress as to therapy for that disease has
been noted.
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